Axel Guilbaud, Ph.D., is a principal scientist at Genentech in the Analytical Development Department,  where he works in the Separation Core Group, focusing on liquid chromatography and capillary electrophoresis technologies. His research centers on developing novel analytical methods to characterize critical quality attributes of therapeutic modalities and help in understanding their biological effects.